Therapeutic Use Exemption - Procedures

Athletes may have illnesses or conditions that require them to take particular medications.

If the medication an athlete is required to take to treat an illness or condition happens to fall under the Prohibited List, a Therapeutic Use Exemption (TUE) may give that athlete the authorization to take the needed medicine.


To whom does this apply?


Athletes who have been identified as included in FINA’s Registered Testing Pool (RTP and TP) and athletes who participate in FINA competitions, may only obtain therapeutic use exemptions in accordance with the rules of FINA.

A FINA’s competition is a competition with FINA in the title (i.e FINA Swimming World Cup, FINA World Juniors


TUE Recognition

FINA does not automatically recognise TUE from other Anti-Doping Organisation. It only requires a quick review by the FINA TUE Committee (TUEC).

Therefore, in the absence of such automatic recognition, the Athlete who has received a TUE from her/his Anti-Doping Organisation, shall submit a request for recognition of the TUE to FINA, either via ADAMS or by email at

The request should be accompanied by a copy of the TUE and the original TUE application form and supporting materials referenced at Articles 6.1 and 6.2 of the WADA TUE Standards (unless the Anti-Doping Organization that granted the TUE has already made the TUE and supporting materials available via ADAMS or other system approved by WADA, in accordance with Article 5.4).


TUE Renewal

IMPORTANT : once a Therapeutic Use Exemptions (TUE) has been approved, it is the responsibility of each athlete to renew their TUEs upon expiry if necessary.


Asthma Medication Clarification / Beta-2 Agonists and Glucocorticosteroids

Asthma Medication TUE REQUIRED
Advair (flucticasone and salmeterol) NO
Bricanyl (terbutaline) YES
Formoterol** NO
Salbutamol (albuterol)* NO
Salmeterol*** NO
Symbicort (budesonide and formoterol) NO


* Inhaled salbutamol: maximum 1600 micrograms over 24 hours in divided doses not to exceed 800 micrograms over 12 hours starting from any dose;


The presence in urine of salbutamol in excess of 1000 ng/mL or formoterol in excess of 40 ng/mL is not consistent with therapeutic use of the substance and will be considered as an Adverse Analytical Finding (AAF) unless the Athlete proves, through a controlled pharmacokinetic study, that the abnormal result was the consequence of a therapeutic dose (by inhalation) up to the maximum dose indicated above.


** Inhaled formoterol: maximum delivered dose of 54 micrograms over 24 hours;


*** Inhaled salmeterol: maximum 200 micrograms over 24 hours.


NB:    Please note that the use of oral or intravenous glucocorticosteroids in the emergency treatment of asthma requires a TUE Application Form.


The Therapeutic Use Exemption Application Form 2019 is available to download here:  TUE FORM

For further information please contact the FINA Office, your national federation or consult the following:

•    World Anti-Doping Agency Prohibited List  

•    WADA International Standard for Therapeutic Use Exemptions

WADA TUE Checklists:

ADHD TUE Application
Adrenal Insufficiency TUE Application
Asthma TUE Application
Cardiovascular Conditions TUE Application
Diabetes TUE Application
Inflammatory Bowel Disease (IBD) TUE Application
iv infusion TUE Application
Male Hypogonadism TUE Application
Muscoskeletal (MSK) TUE Application
Neuropathic Pain TUE Application
Renal Transplantation TUE Application
Sinusitis TUE Application
Sleep Disorders TUE Application
Transgender TUE Application